Barclays’s Yarrow Bioscience YARW Stock Holding History

Barclays’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$92	Buy	+3	New	+$97	﹤0.01%	5200
2024 Q4	–	Sell	-2	Closed	-$188	–	5504
2024 Q3	$188	Buy	+2	New	+$190	﹤0.01%	5167
2020 Q3	–	Sell	-35	Closed	-$219K	–	5614
2020 Q2	$219K	Buy	35 +29	+483%	+$196K	﹤0.01%	3996
2020 Q1	$59K	Buy	6 +2	+50%	+$31.4K	﹤0.01%	5124
2019 Q4	$73K	Buy	4 +2	+100%	+$33.3K	﹤0.01%	5621
2019 Q3	$35K	Sell	2 -1	-33%	-$16.1K	﹤0.01%	6062
2019 Q2	$62K	Buy	3 +2	+200%	+$49.5K	﹤0.01%	5993
2019 Q1	$27K	Buy	+1	New	+$24K	﹤0.01%	6236
2018 Q4	–	Sell	-1	Closed	-$22.4K	–	6843
2018 Q3	$37K	Buy	+1	New	+$30.9K	﹤0.01%	6236
2018 Q2	–	Hold	0	–	–	–	6710
2018 Q1	–	Hold	0	–	–	–	5909

Other funds holding YARW

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return

T3 Companies New York $93.7M AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

KCA

KVP Capital Advisors San Francisco, California $136M AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Barclays's YARW Position: Q2 2026 in Review

Barclays opened a new position in Yarrow Bioscience (YARW) in Q2 2026: 3 shares worth $92. The stake represents ﹤0.01% of the portfolio and ranks #5200 among its holdings. This is a return to the name: Barclays previously reported a position in YARW as recently as Q3 2024.

Barclays first reported a position in YARW in Q3 2018 and has held it in 9 quarters since. The position peaked at $219K in Q2 2020. 40 funds tracked by Wall St. Rank hold YARW as of Q2 2026.

Barclays held 3 shares of Yarrow Bioscience worth $92 as of Q2 2026.
Yarrow Bioscience was a new Barclays position in Q2 2026.
Yarrow Bioscience made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #5200 holding.
Barclays first reported a position in Yarrow Bioscience in Q3 2018 and has held it in 9 quarters since.
Barclays's Yarrow Bioscience position peaked at $219K in Q2 2020.
40 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.